Brief: Actuate Therapeutics Announces Closing Of IPO
14/08/2024 21:12
Aug 14 (Reuters) - Actuate Therapeutics Inc ACTU.O :
* ACTUATE THERAPEUTICS ANNOUNCES CLOSING OF INITIAL PUBLIC
OFFERING
Source text for Eikon: ID:nGNX3PR1Bl
Further company coverage: ACTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actuate Therapeutics
See all newsHealth Rounds: Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing
Brief: Actuate Therapeutics Announces Positive Patient Outcomes From Phase 1 Trial
Brief: Actuate Therapeutics Inc - Enters At The Market Issuance Sales Agreement With B. Riley And Craig-Hallum - SEC Filing